Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Are RNAi Leaders About to Be Snatched Up by Big Pharma?
Seeking Alpha
Sunday, September 12, 2010 - 11:44am
tags:
RNAi
Cempra Pharmaceuticals Presents New Data on TAKSTA(TM) (CEM-102, sodium fusidate) at the 50th IntersConference on Antimicrobial Agents and Chemotherapy (ICAAC)
PR-USA.net
Sunday, September 12, 2010 - 11:43am
tags:
Cempra, infectious diseases, MRSA, Taksta
Gehrig's patients demand Teva reveal Copaxone test results
Ha'aretz
Sunday, September 12, 2010 - 11:40am
tags:
Lou Gehrig's disease, Teva Pharmaceuticals, Copaxone
Wyeth's Ghost in the Medical Machine
Seeking Alpha
Sunday, September 12, 2010 - 11:37am
tags:
Wyeth, Pfizer
Nearly 400 Medicines And Vaccines In Development To Fight Infectious Diseases
Medical News Today
Sunday, September 12, 2010 - 11:35am
tags:
infectious diseases
Merck, J&J arbitration on drug rights starts soon
Las Vegas Sun, NV
Sunday, September 12, 2010 - 11:33am
tags:
Merck, JNJ
Aluminum Content of Infant Formula Remains a Challenge for Pfizer
Seeking Alpha
Sunday, September 12, 2010 - 11:27am
tags:
Pfizer, infant formula, SMA Nutrition
How Much of a Bargain Is Johnson & Johnson Stock Right Now?
Motley Fool
Sunday, September 12, 2010 - 11:24am
tags:
JNJ, investors
Court Denies Class-Action Status in Lilly Drug Case
NY Times
Sunday, September 12, 2010 - 11:23am
tags:
Eli Lilly, Zyprexa, legal
ZYBRESTAT(TM) (CA4P) Improves Overall Survival in a Phase 2/3 Trial (FACT Study) of Patients With Anaplastic Thyroid Cancer (ATC)
Yahoo/Globe NewsWire
Sunday, September 12, 2010 - 11:22am
tags:
Zybrestat, Oxigene, thyroid cancer
Small Cap Biotech Stocks: 7 Picks, 1 Big Concern
Seeking Alpha
Sunday, September 12, 2010 - 11:20am
tags:
Chelsea Therapeutics, Clinical Data, Savient, DUSA pharmaceuticals, Neurologix, Lpath
Idenix Hopes to Resume Course With Hepatitis C Drugs by Year's End
Seeking Alpha
Sunday, September 12, 2010 - 11:17am
tags:
Idenix, hepatitis C, Bristol-Myers Squibb, ZymoGenetics, Vertex Pharmaceuticals, Telaprevir, Regulus, GSK, Merck
U.S. Attorney General: Misuse of prescription painkillers a serious problem
Barre Montpelier Times Argus, VT
Saturday, September 11, 2010 - 2:58pm
tags:
opiates, pain management
RXi Pharmaceuticals in line for partnership/investment deal with Big Pharma. Again?
Smallcap Network
Saturday, September 11, 2010 - 2:56pm
tags:
RXi Pharmaceuticals
FDA gives green light to KV drug manufacturing
St. Louis Post-Dispatch, MO
Saturday, September 11, 2010 - 2:54pm
tags:
KV Pharmaceutical
Kahn Swick & Foti, LLC and Former Louisiana Attorney General Notify XenoPort Shareholders With Large Financial Interests of Securities Fraud Class Action
Yahoo/Businesswire
Saturday, September 11, 2010 - 12:24pm
tags:
XenoPort, legal
Genome Sequencing Going Down Market
Investor's Business Daily
Saturday, September 11, 2010 - 11:39am
tags:
genome sequencing, Illumina
MannKind Evenly Poised
Yahoo/Zacks
Saturday, September 11, 2010 - 11:37am
tags:
MannKind, investors
Hana Biosciences Reverse Stock Split Effective Monday, September 13, 2010
Yahoo/Globe NewsWire
Saturday, September 11, 2010 - 11:36am
tags:
Hana Biosciences, investors
Bristol-Myers Pays A Premium For Its Partner
Investopedia
Saturday, September 11, 2010 - 11:35am
tags:
Bristol-Myers Squibb, ZymoGenetics, Merck Serono, Novo Nordisk

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.